MRK
Merck & Co., Inc. · Healthcare
SVP Fince-Global Controller Rita A Karachun sold $1.9M of Merck & Co., Inc.
Sold$1,865,843
$117.53Price
15,875Shares
−26%Stake
What MRK did after the filing
- The stock from Fri, May 5 close, $117.68
- −6.3%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Jun 20 close.
Traded Thu, May 4. Filed Fri, May 5, 12:54 PM ET, during the session. Returns use the May 5 close and the Jun 20 close. Not investment advice.